Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

21776
1
CervoMed Inc. CervoMed Reports $4.9 Million Net Loss in Q1 2025, Increased R&D Expenses

Via official filing (AI summary) | about 1 year ago | 0 comments

21777
1
Vynleads, Inc. Vynleads Reports $80,970 Net Loss in Q1 2025, Seeks Additional Funding

Via official filing (AI summary) | about 1 year ago | 0 comments

21778
1
BioXcel Therapeutics, Inc. BioXcel Therapeutics Reports $7.254 Million Net Loss and Decreased Product Revenue in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21779
1
FORRESTER RESEARCH, INC. Forrester Research Reports 10% Revenue Decline and $87.3 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21780
1
SONIDA SENIOR LIVING, INC. Sonida Senior Living Reports $13M Net Loss Despite 36.4% Revenue Increase in Latest Quarter

Via official filing (AI summary) | about 1 year ago | 0 comments

21781
1
Centuri Holdings, Inc. Centuri Holdings Reports $550.1 Million Revenue with Improved Gross Profit but Net Loss in Latest Quarter

Via official filing (AI summary) | about 1 year ago | 0 comments

21782
1
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Lixte Biotechnology Reports Decreased Net Loss and Improved Cash Position for Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21783
1
1stdibs.com, Inc. 1stdibs.com Reports 2% Revenue Growth to $22.5 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21784
1
UFP TECHNOLOGIES INC UFP Technologies Reports 41.1% Revenue Growth to $148.1 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21785
1
Imunon, Inc. Imunon Reports $4.1 Million Net Loss in Q1 2025, Decreased Operating Expenses

Via official filing (AI summary) | about 1 year ago | 0 comments

21786
1
MBX Biosciences, Inc. MBX Biosciences Reports $23.9 Million Net Loss in Q1 2025, Increases R&D Spending

Via official filing (AI summary) | about 1 year ago | 0 comments

21787
1
Solo Brands, Inc. Solo Brands Reports 9.5% Decline in Q1 2025 Net Sales, Net Loss Increases to $18.6 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

21788
1
UroGen Pharma Ltd. UroGen Pharma Reports $20.3 Million Revenue in Q1 2025, 7.8% Increase Year-Over-Year

Via official filing (AI summary) | about 1 year ago | 0 comments

21789
1
Neuraxis, INC NeurAxis Reports Q1 2025 Financial Results with Increased Revenue but Higher Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

21790
1
Tharimmune, Inc. Tharimmune Reports $2.54 Million Net Loss and Increased Operating Expenses for Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21791
1
YHN Acquisition I Ltd YHN Acquisition I Limited Reports Q1 2025 Financial Results with Net Income Turnaround

Via official filing (AI summary) | about 1 year ago | 0 comments

21792
1
Luduson G Inc. Luduson G Inc. Reports Revenue Drop to $0 and Net Loss of $3,524 in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21793
1
Akero Therapeutics, Inc. Akero Therapeutics Reports $70.7 Million Net Loss in Q1 2025, Increases R&D Spending

Via official filing (AI summary) | about 1 year ago | 0 comments

21794
1
ProMIS Neurosciences Inc. ProMIS Neurosciences Reports $7.3 Million Net Loss and Increased Operating Expenses for Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

21795
1
Metsera, Inc. Metsera Reports $76.6 Million Net Loss and IPO Proceeds of $288.4 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

21796
1
Wellgistics Health, Inc. Wellgistics Health Reports $10.86M Revenue Growth and $32.43M Net Loss in Latest Quarter

Via official filing (AI summary) | about 1 year ago | 0 comments

21797
1
Sionna Therapeutics, Inc. Sionna Therapeutics Reports $16.5M Net Loss and $199.6M IPO Proceeds in Latest Financial Update

Via official filing (AI summary) | about 1 year ago | 0 comments

21798
1
Tango Therapeutics, Inc. Tango Therapeutics Reports Q1 2025 Financial Results with $39.9M Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

21799
1
Avalo Therapeutics, Inc. Avalo Therapeutics Reports $13.1 Million Net Loss in Q1 2025, Down from $121.3 Million Last Year

Via official filing (AI summary) | about 1 year ago | 0 comments

21800
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports Q1 2025 Financial Results with $18.9M in Net Sales

Via official filing (AI summary) | about 1 year ago | 0 comments